annual cash & cash equivalents:
$453.61M+$198.74M(+77.97%)Summary
- As of today (September 13, 2025), SUPN annual cash & cash equivalents is $453.61 million, with the most recent change of +$198.74 million (+77.97%) on December 31, 2024.
- During the last 3 years, SUPN annual cash & cash equivalents has risen by +$113.93 million (+33.54%).
- SUPN annual cash & cash equivalents is now -1.67% below its all-time high of $461.33 million, reached on December 31, 2022.
Performance
SUPN Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$522.60M+$59.01M(+12.73%)Summary
- As of today (September 13, 2025), SUPN quarterly cash & cash equivalents is $522.60 million, with the most recent change of +$59.01 million (+12.73%) on June 30, 2025.
- Over the past year, SUPN quarterly cash & cash equivalents has increased by +$175.41 million (+50.52%).
- SUPN quarterly cash & cash equivalents is now -17.35% below its all-time high of $632.33 million, reached on March 31, 2023.
Performance
SUPN quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SUPN Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +78.0% | +50.5% |
| 3 y3 years | +33.5% | +44.9% |
| 5 y5 years | - | +39.4% |
SUPN Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.7% | +78.0% | -17.4% | +244.6% |
| 5 y | 5-year | -1.7% | +78.0% | -17.4% | +244.6% |
| alltime | all time | -1.7% | +1810.8% | -17.4% | +4271.0% |
SUPN Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $522.60M(+12.7%) |
| Mar 2025 | - | $463.59M(+2.2%) |
| Dec 2024 | $453.61M(+78.0%) | $453.61M(+12.5%) |
| Sep 2024 | - | $403.21M(+16.1%) |
| Jun 2024 | - | $347.19M(+16.6%) |
| Mar 2024 | - | $297.74M(+16.8%) |
| Dec 2023 | $254.87M(-44.8%) | $254.87M(+27.3%) |
| Sep 2023 | - | $200.19M(+32.0%) |
| Jun 2023 | - | $151.66M(-76.0%) |
| Mar 2023 | - | $632.33M(+37.1%) |
| Dec 2022 | $461.33M(+35.8%) | $461.33M(+17.8%) |
| Sep 2022 | - | $391.79M(+8.6%) |
| Jun 2022 | - | $360.79M(+15.6%) |
| Mar 2022 | - | $312.20M(-8.1%) |
| Dec 2021 | $339.68M(-19.6%) | $339.68M(-23.5%) |
| Sep 2021 | - | $443.85M(+8.3%) |
| Jun 2021 | - | $409.84M(+4.8%) |
| Mar 2021 | - | $391.10M(-7.4%) |
| Dec 2020 | $422.53M(+201.7%) | $422.53M(+20.1%) |
| Sep 2020 | - | $351.95M(-6.1%) |
| Jun 2020 | - | $374.81M(-6.5%) |
| Mar 2020 | - | $400.87M(+186.3%) |
| Dec 2017 | $140.04M(+55.4%) | $140.04M(+55.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $90.12M(+44.9%) | $90.12M(+44.9%) |
| Dec 2015 | $62.19M(+70.9%) | $62.19M(+136.5%) |
| Sep 2015 | - | $26.29M(-20.6%) |
| Jun 2015 | - | $33.11M(+28.3%) |
| Mar 2015 | - | $25.81M(-29.1%) |
| Dec 2014 | $36.40M(+10.4%) | $36.40M(-3.7%) |
| Sep 2014 | - | $37.78M(+216.0%) |
| Jun 2014 | - | $11.96M(-2.4%) |
| Mar 2014 | - | $12.25M(-62.9%) |
| Dec 2013 | $32.98M(-18.2%) | $32.98M(+43.7%) |
| Sep 2013 | - | $22.95M(-32.3%) |
| Jun 2013 | - | $33.91M(+79.3%) |
| Mar 2013 | - | $18.91M(-53.1%) |
| Dec 2012 | $40.30M(-17.0%) | $40.30M(+72.1%) |
| Sep 2012 | - | $23.41M(-50.4%) |
| Jun 2012 | - | $47.24M(+197.8%) |
| Mar 2012 | - | $15.87M(-67.3%) |
| Dec 2011 | $48.54M(+104.5%) | $48.54M(+194.5%) |
| Sep 2011 | - | $16.48M(-30.6%) |
| Dec 2010 | $23.74M(-24.4%) | $23.74M(-6.0%) |
| Sep 2010 | - | $25.26M(-19.6%) |
| Dec 2009 | $31.41M(-40.6%) | $31.41M |
| Dec 2008 | $52.88M | - |
FAQ
- What is Supernus Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Supernus Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Supernus Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of SUPN is $453.61M
What is the all time high annual cash & cash equivalents for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $461.33M
What is Supernus Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, SUPN annual cash & cash equivalents has changed by +$198.74M (+77.97%)
What is Supernus Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SUPN is $522.60M
What is the all time high quarterly cash & cash equivalents for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $632.33M
What is Supernus Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, SUPN quarterly cash & cash equivalents has changed by +$175.41M (+50.52%)